Full corporate governance report 2011 - Straumann

110
operational review
corporate governance
He joined Straumann in 2005 as Head of the Surgical Business
Unit. From 2008 to 2010, he also headed Straumann's
Regenerative Franchise and was a member of the Corporate
Management Group.
Dr Willi holds a Master’s degree in Chemical Engineering,
a PhD in Technical Sciences and a postgraduate degree in
Industrial Engineering and Management, all completed
at the Swiss Federal Institute of Technology in Zurich. He
is also an alumnus of the Medtronic Marketing Leader Pro-
gram at the Wharton School (University of Pennsylvania).
Dr Willi was appointed to his current position at the beginning
of 2012.
CORPORATE MANAGEMENT GROUP 2011
The EMB is supported by the Corporate Management
Group (CMG), which serves as a discussion, sounding and
alignment board for the EMB. On 31 December 2011, the
CMG comprised 17 members: the Sales Heads of: Central
Europe, Western Europe, Iberia, Nordics, Benelux, APAC,
Japan, China, CARES Digital Solutions, and Regenerative; the
Heads of: Global Marketing, Business Unit Surgical, Projects
& Portfolio Planning, Global Operations, Corporate Human
Resources, Corporate Business Development & Licensing,
and the General Counsel.
Changes in 2012
As part of the company’s reorganization, the CMG was redefined
at the beginning of 2012 and expanded slightly to
21 members including: the Sales Heads of Central Europe,
Western Europe, Iberia, Japan, China and North America;
the Heads of Global Distributor Sales, Regenerative, Clinic
Prosthetics, Lab Prosthetics, and Intra-Oral Scanners; the
Market Managers of Surgical and Prosthetics, the Heads of
Communication & Marketing Services, Project & Portfolio
Planning, Product Management Surgical, Global Operations,
Corporate Human Resources, Corporate Business Development
& Licensing, Corporate Accounting, Planning &
Reporting, and the General Counsel.
Almost all of the new positions in the CMG were filled
through internal promotions. The appointment and term
of office of CMG members is decided by the EMB.
SUPERVISORY/CONSULTING/POLITICAL FUNCTIONS
Beat Spalinger is a Member of the Board of Directors and
Board of Trustees of the independent academic network International
Team for Implantology (ITI). Straumann supports
the ITI with payments under a collaboration agreement
(see Note 28 of the Audited Consolidated Financial
Statements on p. 199 for details of payments in 2011).
Sandro Matter is a member of the Industrial Advisory Board
for the Department of Mechanical & Process Engineering of
the ETH Zurich. Apart from these two cases, none of the Executive
Management Board:
• Performed any activities in governing or supervisory
bodies of significant foreign or domestic organizations,
institutions or foundations under private or public law
• Held any permanent management or consultancy function
for significant domestic or foreign interest groups
• Held any official function or political post.
MANAGEMENT CONTRACTS
The Board of Directors and the Executive Management
Board run the business directly. They have not delegated
any managerial powers to persons or companies outside
Straumann.
INTERNAL MANAGEMENT DEVELOPMENT
Straumann continued the Strategic Management Development
System (SMD) program initiated in 2008 to assess, develop
and deploy key people. The Group’s goal is to fill at
least 50% of key management positions with internal candidates.
With the exception of the CFO and the vacant position
of Head of Sales Asia/Pacific, all of the Executive Management
positions have been filled with internal candidates.
For further information on the Company’s SMD program,
see p. 66.